Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-10 4:59 pm Purchase |
2021-11-05 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Flynn James E | 4,203,900 7.190% |
4,203,900 (New Position) |
Filing History |
| 2021-10-26 7:35 pm Purchase |
2021-10-26 | 13G | Xilio Therapeutics, Inc. XLO |
Flynn James E | 2,287,944 8.580% |
2,287,944 (New Position) |
Filing History |
| 2021-09-28 11:29 am Purchase |
2021-09-20 | 13G | Vincerx Pharma, Inc. VINC |
Flynn James E | 68,966 6.560% |
68,966 (New Position) |
Filing History |
| 2021-08-26 4:20 pm Purchase |
2021-08-23 | 13D | Acutus Medical, Inc. AFIB |
Flynn James E | 5,852,924 9.500% |
345 (+0.01%) |
Filing History |
| 2021-08-16 5:06 pm Purchase |
2021-08-04 | 13G | Aerie Pharmaceuticals, Inc. AERI |
Flynn James E | 2,535,501 5.370% |
2,041,285 (+413.03%) |
Filing History |
| 2021-08-05 4:45 pm Purchase |
2021-07-26 | 13G | Apria, Inc. APR |
Flynn James E | 2,431,417 6.900% |
2,431,417 (New Position) |
Filing History |
| 2021-08-02 12:56 pm Purchase |
2021-07-22 | 13G | GeneDx Holdings Corp. WGS |
Flynn James E | 419,651 5.770% |
419,651 (New Position) |
Filing History |
| 2021-07-21 5:13 pm Purchase |
2021-07-19 | 13D | Acutus Medical, Inc. AFIB |
Flynn James E | 5,852,579 17.190% |
1,071,428 (+22.41%) |
Filing History |
| 2021-07-16 3:13 pm Purchase |
2021-07-13 | 13G | Pulmonx Corporation LUNG |
Flynn James E | 1,950,887 5.380% |
1,950,887 (New Position) |
Filing History |
| 2021-07-13 4:52 pm Purchase |
2021-07-11 | 13D | Acutus Medical, Inc. AFIB |
Flynn James E | 4,781,151 16.750% |
5,235 (+0.11%) |
Filing History |
| 2021-07-09 4:57 pm Purchase |
2021-06-29 | 13G | Organogenesis Holdings Inc. ORGO |
Flynn James E | 7,694,363 6.000% |
7,694,363 (New Position) |
Filing History |
| 2021-07-07 2:02 pm Purchase |
2021-07-02 | 13G | TherapeuticsMD, Inc. TXMD |
Flynn James E | 413,256 4.900% |
413,256 (New Position) |
Filing History |
| 2021-07-02 5:08 pm Purchase |
2021-06-30 | 13D | Larimar Therapeutics, Inc. LRMR |
Flynn James E | 5,836,243 32.940% |
686,171 (+13.32%) |
Filing History |
| 2021-07-01 4:50 pm Unchanged |
2021-06-28 | 13D | DFP Healthcare Acquisitions Corp. DFPH |
Flynn James E | 10,460,000 36.380% |
0 (Unchanged) |
Filing History |
| 2021-06-14 5:18 pm Purchase |
2021-06-10 | 13D | HIGHCAPE CAP ACQUISITION CRP U CAPAU |
Flynn James E | 1,400,000 1.690% |
400,000 (+40.00%) |
Filing History |
| 2021-06-03 4:49 pm Purchase |
2021-06-01 | 13G | Singular Genomics Systems, Inc. OMIC |
Flynn James E | 304,734 12.890% |
304,734 (New Position) |
Filing History |
| 2021-05-26 3:53 pm Sale |
2021-03-22 | 13G | Lumos Pharma, Inc. LUMO |
Flynn James E | 161,714 1.940% |
-774,577 (-82.73%) |
Filing History |
| 2021-05-26 1:48 pm Unchanged |
2021-05-25 | 13D | Larimar Therapeutics, Inc. LRMR |
Flynn James E | 5,150,072 33.500% |
0 (Unchanged) |
Filing History |
| 2021-05-21 5:05 pm Purchase |
2021-05-21 | 13D | Larimar Therapeutics, Inc. LRMR |
Flynn James E | 5,150,072 33.500% |
5,533 (+0.11%) |
Filing History |
| 2021-05-21 2:30 pm Purchase |
2021-05-11 | 13G | AdaptHealth Corp. AHCO |
Flynn James E | 21,400,775 5.690% |
1,726,573 (+8.78%) |
Filing History |